Abstract
Astroglial cells are fundamental elements of most neurological diseases, including bipolar disorders in which astrocytes show morphological and functional deficiency. Here we report the suppression of astroglial glutamate release by chronic treatment with three anti-bipolar drugs, lithium salt (Li+), carbamazepine (CBZ) and valproic acid (VPA). Release of glutamate was triggered by transient exposure of astrocytes to ATP (which activated purinoceptors) and 45 mM K+ (which depolarised cell membrane to ~−30 mV). In both types of stimulation glutamate release was regulated by Ca2+ entry through plasmalemmal channels and by Ca2+ release from the endoplasmic reticulum (ER) intracellular stores. Exposure of astroglial cultures to Li+, CBZ and VPA for 2 weeks led to a significant (more than 2 times) inhibition of glutamate release, which may alleviate the hyperactivity of the glutamatergic transmission in the brain of patients with bipolar disorders and thus contribute the underlying mechanism of drug action.
Similar content being viewed by others
References
Bernstein HG, Steiner J, Guest PC, Dobrowolny H, Bogerts B (2015) Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy. Schizophr Res 161(1):4–18
Brennan BP, Hudson JI, Jensen JE, McCarthy J, Roberts JL, Prescot AP, Cohen BM, Pope HG Jr, Renshaw PF, Ongur D (2010) Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology 35(3):834–846
Burda JE, Sofroniew MV (2014) Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81(2):229–248
Chen G, Henter ID, Manji HK (2010) Presynaptic glutamatergic dysfunction in bipolar disorder. Biol Psychiatry 67(11):1007–1009
Czeh B, Fuchs E, Flugge G (2013) Altered glial plasticity in animal models for mood disorders. Curr Drug Targets 14(11):1249–1261
Eastwood SL, Harrison PJ (2010) Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder. Biol Psychiatry 67(11):1010–1016
Giaume C, Kirchhoff F, Matute C, Reichenbach A, Verkhratsky A (2007) Glia: the fulcrum of brain diseases. Cell Death Differ 14(7):1324–1335
Golovina VA (2005) Visualization of localized store-operated calcium entry in mouse astrocytes. Close proximity to the endoplasmic reticulum. J Physiol 564(Pt 3):737–749
Hertz L (2012) Isotope-based quantitation of uptake, release, and metabolism of glutamate and glucose in cultured astrocytes. Methods Mol Biol 814:305–323
Hertz L, Peng L, Lai JC (1998) Functional studies in cultured astrocytes. Methods 16(3):293–310
Jeremic A, Jeftinija K, Stevanovic J, Glavaski A, Jeftinija S (2001) ATP stimulates calcium-dependent glutamate release from cultured astrocytes. J Neurochem 77(2):664–675
Kirischuk S, Parpura V, Verkhratsky A (2012) Sodium dynamics: another key to astroglial excitability? Trends Neurosci 35(8):497–506
Li B, Gu L, Zhang H, Huang J, Chen Y, Hertz L, Peng L (2007) Up-regulation of cPLA2 gene expression in astrocytes by all three conventional anti-bipolar drugs is drug-specific and enzyme-specific. Psychopharmacology 194(3):333–345
Li B, Zhang S, Li M, Zhang H, Hertz L, Peng L (2009) Down-regulation of GluK2 kainate receptor expression by chronic treatment with mood-stabilizing anti-convulsants or lithium in cultured astrocytes and brain, but not in neurons. Neuropharmacology 57(4):375–385
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275
Malarkey EB, Ni Y, Parpura V (2008) Ca2+ entry through TRPC1 channels contributes to intracellular Ca2+ dynamics and consequent glutamate release from rat astrocytes. Glia 56(8):821–835
Martineau M, Parpura V, Mothet JP (2014) Cell-type specific mechanisms of d-serine uptake and release in the brain. Front Synaptic Neurosci 6:12
Michael N, Erfurth A, Ohrmann P, Gossling M, Arolt V, Heindel W, Pfleiderer B (2003) Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology 168(3):344–346
Miguel-Hidalgo JJ, Waltzer R, Whittom AA, Austin MC, Rajkowska G, Stockmeier CA (2010) Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. J Affect Disord 127(1–3):230–240
Ongur D, Drevets WC, Price JL (1998) Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95(22):13290–13295
Ongur D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, Renshaw PF (2008) Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry 64(8):718–726
Parpura V, Zorec R (2010) Gliotransmission: exocytotic release from astrocytes. Brain Res Rev 63(1–2):83–92
Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG (1994) Glutamate-mediated astrocyte-neuron signalling. Nature 369(6483):744–747
Parpura V, Grubisic V, Verkhratsky A (2011) Ca2+ sources for the exocytotic release of glutamate from astrocytes. Biochim Biophys Acta 1813(5):984–991
Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG, Stout RF Jr, Spray DC, Reichenbach A, Pannicke T, Pekny M, Pekna M, Zorec R, Verkhratsky A (2012) Glial cells in (patho)physiology. J Neurochem 121(1):4–27
Pekny M, Pekna M (2004) Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 204(4):428–437
Pekny M, Pekna M (2014) Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev 94(4):1077–1098
Pekny M, Wilhelmsson U, Pekna M (2014) The dual role of astrocyte activation and reactive gliosis. Neurosci Lett 565:30–38
Peng LA, Juurlink BH, Hertz L (1991) Differences in transmitter release, morphology, and ischemia-induced cell injury between cerebellar granule cell cultures developing in the presence and in the absence of a depolarizing potassium concentration. Brain Res Dev Brain Res 63(1–2):1–12
Rajkowska G (2014) Pathology in astroglia, glutamate, and GABA in major depressive disorder: evidence from studies of human postmortem tissue. In: Popoli M, Diamond D, Sanacora G (eds) Synaptic stress and pathogenesis of neuropsychiatric disorders. Springer Science+Business Media, New York, pp 245–264
Rajkowska G, Stockmeier CA (2013) Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets 14(11):1225–1236
Reyes RC, Verkhratsky A, Parpura V (2013) TRPC1-mediated Ca2+ and Na+ signalling in astroglia: differential filtering of extracellular cations. Cell Calcium 54(2):120–125
Sanacora G, Banasr M (2013) From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 73(12):1172–1179
Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32(12):638–647
Song D, Man Y, Li B, Xu J, Hertz L, Peng L (2013) Comparison between drug-induced and K+-induced changes in molar acid extrusion fluxes (JH+) and in energy consumption rates in astrocytes. Neurochem Res 38(11):2364–2374
Verkhratsky A, Krishtal OA, Burnstock G (2009) Purinoceptors on neuroglia. Mol Neurobiol 39(3):190–208
Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodriguez JJ, Nedergaard M (2012) Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 4(3):e00082
Verkhratsky A, Rodriguez JJ, Steardo L (2013) Astrogliopathology: a central element of neuropsychiatric diseases? Neuroscientist 20(6):576–588
Verkhratsky A, Marutle A, Rodriguez-Arellano JJ, Nordberg A (2014a) Glial asthenia and functional paralysis: a new perspective on neurodegeneration and Alzheimer’s Disease. Neuroscientist. doi:10.1177/1073858414547132
Verkhratsky A, Reyes RC, Parpura V (2014b) TRP channels coordinate ion signalling in astroglia. Rev Physiol Biochem Pharmacol 166:1–22
Yan E, Li B, Gu L, Hertz L, Peng L (2013) Mechanisms for L-channel-mediated increase in [Ca2+]i and its reduction by anti-bipolar drugs in cultured astrocytes combined with its mRNA expression in freshly isolated cells support the importance of astrocytic L-channels. Cell Calcium 54(5):335–342
Zarate CA Jr, Manji HK (2008) Bipolar disorder: candidate drug targets. Mt Sinai J Med 75(3):226–247
Acknowledgments
This study was supported by Grant No. 31440048 from the National Natural Science Foundation of China. AV was supported in part by the grant (agreement from August 27 2013 No. 02.B.49.21.0003) between The Ministry of Education and Science of the Russian Federation and Lobachevsky State University of Nizhny Novgorod and by the grant of the Russian Scientific Foundation №14-15-00633.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Handling Editor: N. Singewald.
Z. Liu and D. Song contributed equally to this article.
Rights and permissions
About this article
Cite this article
Liu, Z., Song, D., Yan, E. et al. Chronic treatment with anti-bipolar drugs suppresses glutamate release from astroglial cultures. Amino Acids 47, 1045–1051 (2015). https://doi.org/10.1007/s00726-015-1936-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-015-1936-y